Bioxytran (BIXT) Ratios
Bioxytran Ratios
BIXT's free cash flow for Q2 2026 was $-340.55K. For the 2026 fiscal year, BIXT's free cash flow was increased by $9.23K and operating cash flow was $-349.77K. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.16 | 0.00 | 0.01 | 0.08 | 0.02 |
| Quick Ratio | 0.16 | 0.00 | 0.01 | 0.08 | 0.02 |
| Cash Ratio | 0.16 | 0.00 | 0.01 | 0.08 | 0.02 |
| Solvency Ratio | -0.65 | -1.22 | -1.31 | -0.67 | -0.04 |
| Operating Cash Flow Ratio | -0.16 | -0.03 | -0.24 | -0.49 | -0.52 |
| Short-Term Operating Cash Flow Coverage | -0.42 | -0.05 | -0.40 | -0.83 | -0.80 |
| Net Current Asset Value | $ -2.74M | $ -1.93M | $ -3.22M | $ -3.37M | $ -3.21M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 1.90 | 7.89 | 13.99 | 5.84 | 17.79 |
| Debt-to-Equity Ratio | -0.48 | -0.61 | -0.79 | -0.80 | -0.77 |
| Debt-to-Capital Ratio | -0.93 | -1.57 | -3.80 | -4.03 | -3.32 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | -0.25 | -0.08 | -0.06 | -0.14 | -0.04 |
| Debt Service Coverage Ratio | -1.28 | -1.19 | -1.55 | -0.79 | 0.00 |
| Interest Coverage Ratio | -9.96 | -2.89 | -7.05 | -4.11 | -13.44 |
| Debt to Market Cap | 0.18 | 0.09 | 0.10 | 0.04 | 0.05 |
| Interest Debt Per Share | 0.02 | 0.01 | 0.02 | 0.02 | 0.02 |
| Net Debt to EBITDA | -0.40 | -0.49 | -0.50 | -0.88 | 0.00 |
| Profitability Margins | |||||
| Gross Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EBIT Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EBITDA Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Pretax Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Continuous Operations Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Income Per EBT | 100.00% | 99.44% | 97.93% | 92.72% | 95.97% |
| EBT Per EBIT | 114.51% | 107.06% | 114.40% | 124.52% | 107.44% |
| Return on Assets (ROA) | -322.39% | -1706.40% | -3109.61% | -664.25% | -3642.68% |
| Return on Equity (ROE) | 81.93% | 132.07% | 176.06% | 91.19% | 157.39% |
| Return on Capital Employed (ROCE) | 71.55% | 124.06% | 122.97% | 64.82% | 133.44% |
| Return on Invested Capital (ROIC) | 138.29% | 318.55% | 323.78% | 189.27% | 406.79% |
| Return on Tangible Assets | -413.48% | -45919.31% | -17582.79% | -834.10% | -6005.35% |
| Earnings Yield | -30.50% | -18.99% | -21.26% | -4.46% | -10.22% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Payables Turnover | 13.78 | 22.02 | 5.00 | 3.68 | 0.00 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Working Capital Turnover Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | -26.50 | -16.57 | -73.04 | -99.16 | 0.00 |
| Days of Sales Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 26.50 | 16.57 | 73.04 | 99.16 | 0.00 |
| Operating Cycle | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.01 | -0.00 | -0.01 | -0.02 | -0.02 |
| Free Cash Flow Per Share | -0.01 | -0.00 | -0.01 | -0.02 | -0.02 |
| Dividend Paid and CapEx Coverage Ratio | -105291.00 | -1.98 | -17.50 | -55.99 | -45.96 |
| Capital Expenditure Coverage Ratio | -105291.00 | -1.98 | -17.50 | -55.99 | -45.96 |
| Operating Cash Flow Coverage Ratio | -0.42 | -0.05 | -0.40 | -0.83 | -0.80 |
| Operating Cash Flow to Sales Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Free Cash Flow Yield | -7.56% | -0.67% | -4.07% | -3.33% | -4.08% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -3.28 | -5.26 | -4.70 | -22.43 | -9.78 |
| Price-to-Sales (P/S) Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Price-to-Book (P/B) Ratio | -2.69 | -6.95 | -8.28 | -20.45 | -15.39 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -13.22 | -148.45 | -24.56 | -30.07 | -24.51 |
| Price-to-Operating Cash Flow Ratio | -13.22 | -223.55 | -25.97 | -30.61 | -25.04 |
| Price-to-Earnings Growth (PEG) Ratio | -0.09 | 0.11 | -0.10 | 0.47 | -4.35 |
| Enterprise Value Multiple | -4.18 | -6.09 | -5.77 | -26.77 | 0.00 |
| Enterprise Value | 7.70M | 13.55M | 22.03M | 57.14M | 44.55M |
| EV to EBITDA | -4.18 | -6.09 | -5.77 | -26.77 | 0.00 |
| EV to Sales | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EV to Free Cash Flow | -14.63 | -161.43 | -26.88 | -31.09 | -25.69 |
| EV to Operating Cash Flow | -14.63 | -243.09 | -28.42 | -31.64 | -26.25 |
| Tangible Book Value Per Share | -0.03 | -0.01 | -0.02 | -0.03 | -0.03 |
| Shareholders’ Equity Per Share | -0.03 | -0.01 | -0.02 | -0.02 | -0.03 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income Per Share | -0.02 | -0.02 | -0.03 | -0.02 | -0.04 |
| Tax Burden | 1.00 | 0.99 | 0.98 | 0.93 | 0.96 |
| Interest Burden | 1.15 | 1.07 | 1.14 | 1.24 | 1.07 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.25 | 0.02 | 0.17 | 0.68 | 0.37 |
Currency in USD
